US 6410747
Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias
expired A61KA61K31/40A61K31/407
Quick answer
US patent 6410747 (Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jun 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Jun 25 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/40, A61K31/407, A61P, A61P25/00